Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Sleep Med. 2012 Aug 23;13(10):1307–1312. doi: 10.1016/j.sleep.2012.07.002

TABLE 3.

Cardiometabolic Function

PCOS
Subjects
(n=28)		 Female
Controls
(n=28)		 Male
Controls
(n=28)		 P value
ANOVA)
1MetS (n) (%) 10 (35.7%) 4 (14.3%) 5 (17.6%) 0.1
Fasting Glucose (mg/dl) 96.6 ± 20.1 85.3 ± 13.5 94.6 ± 13.1 0.02
Fasting Insulin (IU) 30.1 ± 18.5 20.4 ± 6.8 21.3 ± 12.8 0.03
2HOMA-IR >4 71.4%* (20/28) 41.0% (9/22) 34.8% (8/23) <0.05
Fasting TG (mg/dl) 125.5 ± 73.1 91.4 ± 38.9 110.4 ± 44.7 0.08
Fasting HDL (mg/dl) 43.0 ± 10.9** 50.5 ± 13.8 38.3 ± 7.1 0.001
Systolic blood pressure (mmHg) 122.9 ± 13.6 117.1 ± 9.6 128.5 ± 11.5 0.002
Diastolic blood pressure (mmHg) 69.8 ±11.2 66.4 ± 8.4 66.4 ± 8.1 0.3

Data represented as mean ± SD

Bonferroni adjustment:

*

p=0.04 compared to female control group, p=0.01 compared to male control group

**

p<0.05 compared to female controls p=0.4 compared to male control group

1

MetS; metabolic syndrome based on Weiss criteria(21)

2

HOMA-IR; fasting glucose (mg/dL) × fasting insulin (μU/mL)/405.